跳至主要内容
临床试验/JPRN-UMIN000012541
JPRN-UMIN000012541已完成未知

A prospective, randomized controlled trial assessing the efficacy and safety of cilostazol and aspirin therapy versus aspirin therapy for the prevention of vascular events in patietns undergoing coronary stent implantation - CATS-I Trial: Cilostazol and Aspirin versus Aspirin Therapy against Vascular Events after Coronary Stent Implantation Trial

Koseikai Takai Hospital0 个研究点目标入组 700 人开始时间: 2013年12月10日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) hemostatic disorder or active pathologic bleeding, including hemophilia, capillary fragility, intracranial hemorrhage, gastrointestinal bleeding, urinary tract bleeding, hemoptysis and vitreous hemorrhage 2) Known allergy to aspirin or cilostazol 3) Malignancies or other comorbid conditions with a life expectancy of less than 2 years 4) Planned major surgery necessitating discontinuation of antiplatelet therapy within the 2 years after enrollment 5) Pregnancy 6) Circumstances that would have made follow-up impossible

研究者

发起方
Koseikai Takai Hospital

相似试验

A prospective, randomized controlled trial assessing... | 临床试验